BIONPHARMA INC FDA Approval ANDA 040430

ANDA 040430

BIONPHARMA INC

FDA Drug Application

Application #040430

Application Sponsors

ANDA 040430BIONPHARMA INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL250MG0ETHOSUXIMIDEETHOSUXIMIDE

FDA Submissions

ORIG1AP2002-10-28
LABELING; LabelingSUPPL4AP2008-03-03
LABELING; LabelingSUPPL5AP2009-12-10
LABELING; LabelingSUPPL6AP2011-12-27
REMS; REMSSUPPL7AP2012-10-19
LABELING; LabelingSUPPL8AP2014-01-07STANDARD
LABELING; LabelingSUPPL13AP2020-04-01STANDARD
LABELING; LabelingSUPPL19AP2022-02-16STANDARD

Submissions Property Types

SUPPL5Null7
SUPPL6Null15
SUPPL7Null17
SUPPL8Null15
SUPPL13Null7
SUPPL19Null7

TE Codes

001PrescriptionAB

CDER Filings

BIONPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40430
            [companyName] => BIONPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ETHOSUXIMIDE","activeIngredients":"ETHOSUXIMIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ETHOSUXIMIDE","submission":"ETHOSUXIMIDE","actionType":"250MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.